啟明醫療(02500.HK): 2019年度業績的審計程序已經完結
格隆匯4月20日丨啟明醫療(02500.HK)宣佈,2019年度業績的審計程序已經完結,公司已根據上市規則第13.49(2)條的規定取得公司核數師安永會計師事務所對未經審核業績公告所載2019年度業績(包括該公告所載本集團截至2019年12月3日止1年度的綜合損益及其他全面收益表、綜合財務狀況表及相關附註的相關數字)的同意。未經審核業績公告所載2019年度業績維持不變。
此外,有關建議採納限制性股票激勵計劃,根據激勵計劃公告,董事會建議採納限制性股票激勵計劃以進一步完善公司治理結構,充分調動核心員工的積極性,支持公司戰略實現和可持續發展。根據限制性股票激勵計劃,董事會將酌情選擇包括公司董事、高級管理人員以及公司認為應當激勵的核心技術人才和業務骨幹為激勵對象,向其授予限制性股票。限制性股票激勵計劃須待公司股東通過相關普通決議案後,方可作實。
經計及就限制性股票激勵計劃的實際實施與中國國家外匯管理局浙江省分局的深度及持續探討後,公司決定不在將於2020年5月21日(星期四)舉行的應屆年度股東大會上提呈限制性股票激勵計劃及相關普通決議案以供股東批准。公司將適時公佈限制性股票激勵計劃的任何進展及(倘恰當)於適時召開的股東大會上提呈限制性股票激勵計劃及相關決議案以供股東批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.